The India business, accounting for a third of the company’s total revenues, grew at 11%. This is a volume-led growth aided by new product launches. Sun’s India business grew higher than the Indian Pharma market growth. The company launched 14 new products during the quarter.
Will BDL, HAL & other defence stocks deliver rocketing returns? Here’s why this brokerage remains bullish
India’s defence sector is gaining momentum on the back of rising defence spending, localisation, strong order pipelines and growing exports. Bajaj Broking remains bullish on